Biosimilars: Imitation Games-Reference-Cited by-同舟云学术

Biosimilars: Imitation Games

Published:2017-06-09 Issue:7 Volume:8 Page:690-693
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Dahodwala Hussain¹,Sharfstein Susan T.²^ORCID

Affiliation:

1. Vaccine Production Program, VRC/NIAID/NIH, 9 West Watkins Mill Road, Suite 250, Gaithersburg, Maryland 20878, United States

2. Colleges of Nanoscale Science and Engineering, SUNY Polytechnic Institute, 257 Fuller Road, Albany, New York 12203, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.7b00199

Reference13 articles.

1. FDA in the Twenty-First Century

2. Van Arnum, P.Biosimilars: Market Weaknesses and Strengths Biosimilars represent an emerging niche in the biopharmaceutical market, but how strong is their true potential?http://www.pharmtech.com/biosimilars-market-weaknesses-and-strengths.

3. Next-generation optimized biotherapeutics — A review and preclinical study

5. European Medicines Agency workshop on biosimilar monoclonal antibodies

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovator Biologics, Biosimilars, and Biobetters;Biologics, Biosimilars, and Biobetters;2020-12-30

2. The fickle CHO: a review of the causes, implications, and potential alleviation of the CHO cell line instability problem;Current Opinion in Biotechnology;2019-12

3. The Case for Disclosure of Biologics Manufacturing Information;Journal of Law, Medicine & Ethics;2019

4. Viral Vectors for Treatment of Human Disease: Therapeutic and Manufacturing Challenges;Nucleic Acid Nanotheranostics;2019